Thermo Fisher Scientific Inc. (1TMO)
MTA
541.60
+6.80 (+1.27%)
Closed
Aug 24, 2026
Day's Range
536.60542.80
52 wk Range
374.30542.80
Financial Statements - 1TMO - Thermo Fisher Scientific Inc.
Revenue
44.55B▲ 24.3%
Net Income
6.72B▲ 26.9%Net Margin 15.1%
EBITDA
11.85B▲ 19.3%
Free Cash Flow
6.29B▲ 3.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 44.55B | 35.83B |
| Cost of Goods | 26.31B | 21.04B |
| Gross Profit | 18.23B | 14.79B |
 Operating Expense | - | - |
| Operating Income | 8.11B | 6.45B |
| Non-Operating Interest | - | - |
| Other Income Expense | -374M | -306.74M |
| Pre Tax Income | 7.30B | 5.88B |
| Income Tax | 547M | 549.13M |
| Net Income | 6.72B | 5.29B |
| EPS Basic | 17.77 | 16.58 |
| EPS Diluted | 17.74 | 16.53 |
| Basic Shares Outstanding | 377M | 319.28M |
| Diluted Shares Outstanding | 377M | 319.28M |
| Ebit | 8.72B | 7.04B |
| Ebitda | 11.85B | 9.94B |
| Net Income Continuous Operations | 6.72B | 5.29B |
| Minority Interests | -17M | -3M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
